删除或更新信息,请邮件至freekaoyan#163.com(#换成@)

Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway

本站小编 Free考研考试/2022-01-02

Li Yang,
Jing Chen,
Xiaoyan Han,
Enfan Zhang,
Xi Huang,
Xing Guo,
Qingxiao Chen,
Wenjun Wu,
Gaofeng Zheng,
Donghua He,
Yi Zhao,
Yang Yang,
Jingsong He,
Zhen Cai
Multiple Myeloma Treatment Center & Bone Marrow Transplantation Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China
Funds: This work was supported by the National Natural Science Foundation of China (Grant Nos. 31371380, 91429302, and 81641131).

Received Date: 2017-10-04
Rev Recd Date:2017-12-08




Abstract
Clinical success of the proteasome inhibitor established bortezomib as one of the most effective drugs in treatment of multiple myeloma (MM). While survival benefit of bortezomib generated new treatment strategies, the primary and secondary resistance of MM cells to bortezomib remains a clinical concern. This study aimed to highlight the role of p53-induced RING-H2 (Pirh2) in the acquisition of bortezomib resistance in MM and to clarify the function and mechanism of action of Pirh2 in MM cell growth and resistance, thereby providing the basis for new therapeutic targets for MM. The proteasome inhibitor bortezomib has been established as one of the most effective drugs for treating MM. We demonstrated that bortezomib resistance in MM cells resulted from a reduction in Pirh2 protein levels. Pirh2 overexpression overcame bortezomib resistance and restored the sensitivity of myeloma cells to bortezomib, while a reduction in Pirh2 levels was correlated with bortezomib resistance. The levels of nuclear factorkappaB (NF-κB) p65, pp65, pIKBa, and IKKa were higher in bortezomib-resistant cells than those in parental cells. Pirh2 overexpression reduced the levels of pIKBa and IKKa, while the knockdown of Pirh2 via short hairpin RNAs increased the expression of NF-κB p65, pIKBa, and IKKa. Therefore, Pirh2 suppressed the canonical NF-κB signaling pathway by inhibiting the phosphorylation and subsequent degradation of IKBa to overcome acquired bortezomib resistance in MM cells.
Keywords: bortezomib,
drug resistance,
multiple myeloma,
NF-κB,
Pirh2



PDF全文下载地址:

http://www.protein-cell.org/article/exportPdf?id=3f2ab0fe-35f5-4ac1-a3e7-aaa25ab2bd1e&language=en
相关话题/Pirh2 mediates sensitivity